← All trials
NCT02265809
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2014
- Primary completion
- May 1, 2016
- Completion date
- Oct 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 41
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- University of CambridgeLead sponsor
- University of CambridgeOverall official - principal investigator
- University of CambridgeStudy chair
- University of CambridgeCollaborator
- Sir Jules Thorn Charitable TrustCollaborator
- Juvenile Diabetes Research FoundationCollaborator
- Wellcome TrustCollaborator
- National Institute for Health Research, United KingdomCollaborator
- University of CambridgeReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.